Market Newsdesk

NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) resulting from allegations that Penumbra may have issued materially misleading business information to the investing public.

On November 10, 2020, Quintessential Capital Management released research report on the Company entitled “Penumbra and its ‘Killer Catheter’: A tale of corporate greed and seemingly blatant disregard for patients’ lives[.]”

On December 8, 2020, Quintessential Capital Management released a follow-up research report entitled “Is Penumbra’s core scientific research authored by a fake person?: The incredible story of Penumbra’s Dr. Antik Bose[.]” The follow-up report alleged that some of the Company’s scientific research pieces appear to have been incorrectly attributed or even authored by a fake individual. On this news, Penumbra’s share price fell $19.95 per share, or almost 9%, to close at $204.07 per share on December 8, 2020.

On December 15, 2020, after the markets closed, Penumbra announced that it was “voluntarily recalling all configurations” of its JET 7 Xtra Flex Reperfusion Catheter “because the catheter may become susceptible to distal tip damage during use.”

Following the recall, Penumbra’s shares fell $13.84 per share, or 7.3%, to close at $174.98 on December 16, 2020.

Rosen Law Firm is preparing a securities lawsuit on behalf of Penumbra shareholders. If you purchased securities of Penumbra please visit the firm’s website at http://www.rosenlegal.com/cases-register-2003.html to join the securities action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40^th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        [email protected]
        [email protected]
        www.rosenlegal.com

CALGARY, Alberta, Dec. 22, 2020 (GLOBE NEWSWIRE) — On December 21, 2020 Biosenta’s U.S. licensing partner Kleen Bee Labs, LLC has secured licensing rights in Ralphs and Food 4 Less retailers, which are divisions of Kroger Corp. Kroger Corp is one of the largest retailers in the US with approx. 2,400 stores. Kleen Bee Labs long term goal is to distribute in over 10,000 stores across the United States.

Kleen Bee Labs’ previously announced deal will ensure Biosenta’s patented formulation will continue to expand and be sold at scale across North America. The distributor will cover all costs associated with marketing, warehousing, transportation logistics, and retail space fees.

Biosenta is on pace to receive its first royalty payment from Kleen Bee Labs by the end of December.

About Biosenta Inc.

Biosenta develops and manufactures a range of wet and dry anti-microbial chemical compounds for household and industrial applications using active material, and advanced encapsulated nanotechnology.

Disclaimer

In no way, the CSE has passed upon the contents of this news release and further has neither approved nor disapproved of the contents of this news release. Neither the CSE nor it’s Regulation Services Provider (as such term is defined in the CSE) accepts responsibility for this release’s adequacy or accuracy.

Biosenta Digital channel:

https://www.Biosenta.com

Contact Information:

Am Gill
President and CEO
T: 416-410-2019

Minneapolis, MN, Dec. 22, 2020 (GLOBE NEWSWIRE) — Provation, the premier software provider of procedure documentation and clinical decision support solutions, today announced the successful launch of the Provation^® Clinical Content Shop. This unique online store offers hundreds of evidence-based order sets and care plans specific to hundreds of medical conditions – from influenza and COVID-19 to cardiac surgery and much more.

“We wanted to think outside of the box with the Provation Clinical Content Shop. Opening the doors to this digital store allows us to now offer our trusted order sets and care plans à la carte,” said Daniel Hamburger, CEO of Provation “By using this approach, we’re making clinical decision support more accessible for healthcare units of all sizes – from a single in-home care provider to large hospital teams, and everyone in between.”

The Provation Clinical Content Shop includes extensive libraries for Inpatient Order Sets, Outpatient Order Sets, Emergency Order Sets, and Care Plans using the latest evidence and best practices.

Innovation that Delivers Affordable and Credible Clinical Resources

At the onset of COVID-19, Provation set out to innovate ways to provide clinicians with affordable resources to deliver quality healthcare. Through this process emerged the idea of offering clinical content as a service. In March, Provation started to offer free evidence-based COVID-19 order set and care plan PDFs to all healthcare professionals. Since then, its high download rate has shown the immediate and critical need for trusted on-demand clinical content.

“Our goal with the Provation Clinical Content Shop is to make quality healthcare more accessible for providers and their patients,” said Tanni Stone-Dorshow, MD, Principal Writer Analyst Provation. “By offering our trusted medical content on-demand through this online storefront, we can arm healthcare professionals with the latest evidence and best practices in a way that is both convenient and affordable for them.”

Provation has a team of dedicated clinicians that ensure the order sets and care plans offered in the Provation Clinical Content Shop are built on the best available evidence to give providers confidence at the point of care.

About Provation

Provation is a leading provider of healthcare software and SaaS solutions. Our purpose is to empower providers to deliver quality healthcare for all. We provide innovative solutions in clinical productivity, care coordination, quality reporting and billing. Celebrating 25 years, Provation serves thousands of hospitals, surgical facilities, anesthesia groups, and medical offices, including 43 of the top 50 U.S. hospitals for gastroenterology (GI) and GI surgery. Our comprehensive portfolio spans the entire patient procedure, from pre-op through post-op recovery and follow-up, with solutions for physician and nursing documentation (Provation^® MD, Provation^® Apex, MD-Reports and Provation^® MultiCaregiver), patient engagement, surgical care coordination, quality reporting, and billing capture (Provation^® SurgicalValet™), order set and care plan management (Provation^® Order Set Advisor and Provation^® Care Plans), and EHR embedded clinical documentation (Provation^® Clinic Note). Provation is headquartered in Minneapolis, MN and backed by Clearlake Capital Group, L.P. For more information about our solutions, visit provationmedical.com and follow us on Twitter, Facebook and LinkedIn.

Attachments

• Hamburger_Daniel_0018_cropped
• Tanni Dorshow-Stone_cropped

ROUYN-NORANDA, Québec, Dec. 22, 2020 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz Stock Exchangesand GLBXF – OTCQX International in the US) wishes to inform shareholders of the following:

Globex has engaged Novatem to undertake a detailed (25m spacing) aeromagnetic survey over our large Opinaca River gold property located on strike to the southwest of Azimut’s gold discovery. The property covers 13 kilometers of the rock units that house the Elmer gold discovery and totals 65 claims including 4 separate claims to the north such that our 3431-ha land package also adjoins on both the south and northwest of Dios’s K2 gold target which Dios has just completed drilling.

Subject to court approval, Globex has acquired a permitted Silica Quarry in Wyse Township, Ontario, located near the Quebec border west of the town of Temiscaming, Quebec. Included in the purchase are an array of stackers, two 43-foot house trailers, a large hydraulic shovel, a generator and miscellaneous other equipment. The property has a large historical resource of high-grade silica grading in the range of +98% SiO_2.

Globex has optioned the Lac Suzanne Nord, nickel, copper, cobalt property to Enertourbe Inc. The property consists of 3 claim packages totaling 23 claims (1,278 ha). Numerous showings of nickel, copper and cobalt in sulphides occur on all the claim packages.

We have also signed a number of CA’s wherein companies are undertaking due diligence on a number of Globex’s properties. Data has been made available to the various parties and studies are ongoing.

The price of metals has been rising steadily in particular as it relates to gold, copper and zinc. The rising zinc price is reflected in rising royalty payments from Nyrstar’s operations at our Mid-Tennessee royalty property. Payments currently have risen to over $100,000 per month and are expected to rise further as the zinc price continues to climb.

Globex currently has a strong cash and share positions of other companies, no debt, owns all it’s 190 assets and has only fifty-five million shares issued and outstanding. Revenue from options continues. Tres-Or, for example, has confirmed that the $200,000 option payment on the Fontana gold property will be made by January 11, 2021.

Various companies are working on Globex royalty properties including O3 on our Nordeau East and West assets, located east of Val-d’Or, Quebec, Tres-Or and Kiboko on our optioned Fontana gold property, Renforth Resources currently completing a first phase 7,000 metre drill program of a 15,000 m program on our Parbec gold royalty property, Radisson Mining drilling on adjoining claims on gold zones that plunge into Globex’s Kewagama Gold Mine royalty asset, Excellon Resources completing over 14 drill holes on our

Silver City option in Saxony, Germany, Starr Peak undertaking a magnetometer survey on our Normetal/Normetmar base metal mines royalty property and surface sampling on our Rousseau and Lac Turgeon gold royalty properties, BMEX drilling on our Tut gold royalty property, Eros Resources Corporation undertaking permitting and engineering work to advance the Bell Mountain gold/silver property to production, Nippon Dragon Resources starting underground operations at the Globex royalty, Rocmec 1 gold deposit, Maganese X Energy Corp. completing 28 drill holes totaling 4,509 m on Globex’s Battery Hill Manganese royalty property, among others.  

At Globex, we have also been focused on acquiring an understanding the potential of our various advanced assets and have completed 3D models of a number of our advanced properties, including the Francoeur Gold Mine, Vauze polymetallic mine, Ramp Gold Mine, Wrightbar Gold Mine, Tarmac Gold Zones, Standard Gold Mine, Lac Fortune Gold Mine, Blackcliff Gold Mine (in partnership with Altai Resources), among others.

We have flown detailed aeromagnetic surveys over our Francoeur/Arntfield/Lac Fortune gold property, Silidor/New Marlon Gold Mine property, Standard Gold Mine property, Blackcliff Gold Mine property (in partnership with Altai Resources), Laguerre/Knutson gold property, our Courville, Venus, Randall and Napping Dwarf properties and our McNeely lithium project. Novatem have been engaged to fly a number of other Globex properties starting in the new year.

This press release was written by Jack Stoch, Geo., President and CEO of Globex in his capacity as a Qualified Person (Q.P.) under NI 43-101.

Forward Looking Statements: Except for historical information, this news release may contain certain “forward looking statements”.  These statements may involve a number of known and unknown risks and uncertainties and other factors that may cause the actual results, level of activity and performance to be materially different from the expectations and projections of Globex Mining Enterprises Inc. (“Globex”).  No assurance can be given that any events anticipated by the forward-looking information will transpire or occur, or if any of them do so, what benefits Globex will derive therefrom.  A more detailed discussion of the risks is available in the “Annual Information Form” filed by Globex on SEDAR at www.sedar.com

Washington, D.C., Dec. 22, 2020 (GLOBE NEWSWIRE) — The Bay Area Air Quality Management District (BAAQMD) has selected ICMA-RC as recordkeeper for its 401(a) and 457 defined contribution retirement plans, which includes $100 million in assets. BAAQMD serves as the public agency that regulates the stationary sources of air pollution in the nine counties of California’s San Francisco Bay Area. 

“The Bay Area Air Quality Management District is excited to partner with ICMA-RC as the provider for our deferred compensation and money purchase pension plans,” said Judy Yu, Human Resources Manager. “With ICMA-RC’s extensive experience in managing retirement plans and dedicated services to public sector agencies, we have the confidence that they will meet the retirement needs of our employees and retirees.  We look forward to working with ICMA-RC and continuing to build and enhance our retirement plans.”

Previously, BAAQMD offered its employees several plans managed by multiple providers. After completing a benchmark analysis, it determined that moving to a single provider would lead to a substantial savings and enhance its service offerings.

“We are pleased to be partnering with the amazing team at Bay Area Air Quality Management District to provide employees with retirement education, unbiased advice, and financial planning.  For half a century, we have been focused on the unique retirement needs of those dedicated public servants who serve their communities to help them save toward a more secure and confident financial future,” said ICMA-RC’s Senior Vice President, Orlando Cruz.  “We are committed to continuing to provide an unparalleled experience and we look forward to delivering the highest level of service to the employees of Bay Area Air Quality Management District.” 

About ICMA-RC

Founded in 1972, ICMA-RC is a non-profit, independent financial services corporation with approximately $63 billion in assets under management and administration (as of September 30, 2020), focused on providing retirement plans and related services for over 1.5 million public participant accounts. ICMA-RC’s mission is to help those who serve their communities work towards achieving their retirement savings goals. For more information, visit www.icmarc.org, download ICMA-RC’s mobile app from the App Store® or Google Play^TM or follow ICMA-RC on Facebook, LinkedIn and Twitter.

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

December 22, 2020

Royal Dutch Shell plc (the “Company”) has been notified that following the payment of the interim dividend on December 16, 2020 in respect of the third quarter of 2020, the following Persons Discharging Managerial Responsibilities (“PDMRs”) acquired dividend shares in respect of shares previously delivered to them under the annual bonus and/or shares previously vested under employee share plans and held in a Share Plan Account. Further information can be found in the Royal Dutch Shell plc Annual Report and Form 20-F for the year ended December 31, 2019 (www.shell.com/annualreport).

The Notification of Dealing Form for each PDMR can be found below.
                                                               
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.
                                                               
Anthony Clarke                                                
Deputy Company Secretary                                       
                                                               
ENQUIRIES                                                         
                                                               
Shell Media Relations                                                    
International, UK, European Press: +44 20 7934 5550

               
LEI number of Royal Dutch Shell plc: 21380068P1DRHMJ8KU70   
Classification: Additional regulated information required to be disclosed under the laws of a Member State.